News and presentations

The ARCHERY team are pleased to confirm the study has reached it's recruitment target of 330 for the prostate cancer patient group! Since recruiting the first participant in December 2023, our sites in India, Jordan, Malaysia and South Africa have worked hard to meet these targets and you can read more about the teams involved on our centres pages here. The study plans to recru ...

We are delighted to confirm that ARCHERY has now surpassed 75% of its recruitment goal! We have consented 900 participants with 67 withdrawals, reaching a total of 833 currently enrolled participants. This means we have reached just over 84% of our goal of 990.  See below for a breakdown of our progress so far by site. For more regular updates on recruitment figures see our C ...

As ARCHERY comes up on 18 months open to recruitment here is another recruitment update! We have consented 744 participants with 54 withdrawals, reaching a total of 690 enrolled participants. This means we have reached 69.7% of our goal of 990.  See below for a breakdown of our progress so far by site. For more regular updates on recruitment figures see our Current Recruitmen ...

The work ARCHERY is doing was mentioned in the Oncology Commission from The Lancet in November 2024. You can read the full paper linked below. All publications related to ARCHERY are listing on our Publications page. Radiotherapy and theranostics: a Lancet Oncology Commission – The Lancet Oncology “Following on from the 2015 Lancet Oncology Commission on expanding global acce ...

As ARCHERY passes 6 months open to recruitment here is our first recruitment update! We have consented 161 participants with 5 withdrawals, reaching a total of 156 enrolled participants. This means we have reached 15.75% of our goal of 990.  See below for a breakdown of our progress so far by site. For more regular updates on recruitment figures see our Current Recruitment Fi ...

Archery is funded by Rising Tide and NIH